The combined molecular adjuvant CASAC enhances the CD8+ T cell response to a tumor-associated self-antigen in aged, immunosenescent mice.

Immun Ageing · 2015 · PMC4495856 · PMID 26157468

Europe PMC DOI

hedged sentence

0.0673

closest p · 1.3× alpha

0.0673

boldest claim

The sentences

did not reach statistical significancep = 0.0673so close (0.05 < p ≤ 0.1)

Distribution of SVL-specific CD8+ T cell frequencies was higher in the SVL + CASAC-vaccinated group (median 2.5 %) compared to the SVL + CFA/IFA-vaccinated group (0.7 %), although the difference did not reach statistical significance ( p = 0.0673; Fig. 3a ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.